Laurent Levy
Co-Founder, President of the Executive Board & CEODr. Laurent Lévy, Ph.D. has been the President of the Executive Board at Nanobiotix S.A. since May 27, 2004 and its Chief Executive Officer since March 2003. Dr. Lévy has a thorough understanding of the technical, scientific and marketing of nanotechnologies, since he has been working with these tools for years. He has extensive experience in sciences and techniques related to nanotechnologies, a field in which he has worked for more than 10 years. His research at the frontier of biotechnology and nanotechnologies has resulted in the development of a number of concrete applications such as NanoXray, which could open a new method for cancer treatment. His leading work at the frontier of biotechnologies and nanotechnologies has permited to develop a large number of applications such as NBTXR3. He has also worked for years in business development with major health care industry players (Aventis, Guerbet, Rhodia, L'Oreal) and biotechnologies startup. He is the author of 35 international publications and communications and of a patent in this area and regularly speaks on the topic of using nanoparticles to fightcancer, including at a recent TEDxParis event. He serves as Independent Chairman of the Supervisory Board at Valbiotis SA since March 7, 2017, as a founding member of the Nano medicine Translation Advisory Board since June 2014 and served as its Vice Chairman of the executive board of the European Technology Platform on Nano medicine since December 2012 to June 2019. Prior to joining Nanobiotix, from 2000 to 2003, he served as consultant for Altran Technologies and worked in the development of the application of nanotechnologies with companies such as Sanofi S.A., Guerbet S.A. and Rhodia S.A., as well as for early-stage biotechnology companies. He carried out his postdoctoral work at the Institute for Laser Photonics and Biophotonics at the State University of New York (SUNY), Buffalo. Mr. Lévy studied Doctorate in Physical Chemistry specialized in nanomaterials from Pierre et Marie Curie University-CEA (Atomic Energy Agency, Saclay, France) and holds a DEA in Physics of condensed matter from The City of Paris Industrial Physics and Chemistry Higher Educational Institution (École supérieure de physique et de chimie industrielles de la Ville de Paris) (UPVI-ESPCI).
Positions
- Company NameNanobiotix S.A.Stock CodeNBTXPositionCo-Founder, President of the Executive Board & CEOColleagues
- GMGary M. PhillipsIndependent Chairman of Supervisory board
- AHAnne-Juliette HermantChief People Officer & Member of Executive Board
- LKLouis KayitalireChief Medical Officer & Member of Executive Board
- EJEarl J. BergeyCo-Founder
- ACArnd ChristCFO & Member of Executive Board
- AGAnne-Marie GraffinIndependent Vice Chairwoman of the Supervisory Board
- LALeonard A. FarberChief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board
- ESEnno SpillnerIndependent Member of Supervisory Board
- AHAlain HerreraIndependent Member of Supervisory Board
